Working… Menu

Ranibizumab to Treat Type 2 Idiopathic Macular Telangiectasia (RAMA-Trial)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00504400
Recruitment Status : Completed
First Posted : July 20, 2007
Last Update Posted : September 22, 2009
Information provided by:
University Hospital, Bonn